Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis

Author:Arnold, Douglas L.   Freeman, Leorah   Hartung, Hans-Peter   Montalbán, Xavier   Cohen, Jeffrey A.   Bar-Or, Amit   Steinman, Lawrence   DeLuca, John   Cheng, Chun-Yen   Riolo, Jon V.   Silva, Diego   Pachai, Chahin   Cree, Bruce A. C.   

Session Name:P5: MS Prognosis/Epidemiology  

Topic:MS and Inflammatory Disease  

Program Number:P5.010  

Author Institution:NeuroRx Research and Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada, Montréal, QC, Canada  Dell Medical School, The University of Texas at Austin, Austin, Texas, Austin, TX  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Australia  Department of Neurology, Medical University of Vienna, Austria  and Palacký University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic  Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, PA  Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, California, Stanford, CA  Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, Newark, NJ  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA  

Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS Study

Author:De Stefano, Nicola   Achiron, Anat   Barkhof, Frederik   Chan, Andrew   Derfuss, Tobias   Hodgkinson, Suzanne   Leocani, Letizia   Montalban, Xavier   Prat, Alexandre   Schmierer, Klaus   Sellebjerg, Finn   Vermersch, Patrick   Wiendl, Heinz   Keller, Birgit   Smyk, Andrzej   Gardner, Lidia   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.018  

Author Institution:Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy  Multiple Sclerosis Center, Sheba Academic Medical Center, Ramat Gan, Israel  Department of Radiology, VU University Medical Center, Amsterdam, Netherlands  Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland  Department of Neurology, University Hospital Basel, Basel, Switzerland  Ingham Institute for Applied Medical Research, University of New South Wales Medicine, Sydney, Australia  Experimental Neurophysiology Unit, Vita-Salute San Raffaele University, Milan, Italy  Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain  Department of Neurosciences, Université de Montréal, Montreal, QC, Canada  The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom  Danish MS Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark  Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France  Department of Neurology, Institute of Translational Neurology, University of Münster, Muenster, Germany  the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  EMD Serono Research and Development Institute, Inc., Billerica, MA, USA , Billerica, MA  

Effect of Antiplatelet Therapy in Acute Ischemic Stroke with Tandem Lesions

Author:Farooqui, Mudassir   Galecio-Castillo, Milagros   Divani, Afshin   Malik, Amer   Petersen, Nils   Abraham, Michael   Fifi, Johanna   Guerrero, Waldo   Siegler, James   Nguyen, Thanh   Sheth, Sunil   Yoo, Albert   Linares, Guillermo   Janjua, Nazli   Zaidi, Syed   Kobsa, Jessica   Prasad, Ayush   Ikram, Asad   Zevallos, Cynthia   Quispe Orozco, Darko   Requena, Manual   Olive Gadea, Marta   Qureshi, Abid   Barkley, Tiffany   Dajles, Andres   Matsoukas, Stavros   Rana, Ameena   Abdalkader, Mohamad   Marioni, Sergio   Soomro, Jazba   Vivanco-Suarez, Juan   Edgell, Randall   Mokin, Maxim   Yavagal, Dileep   Jumaa, Mouhammad   Hassan, Ameer   Ortega-Gutierrez, Santiago   

Session Name:P7: Cerebrovascular Disease and Interventional Neurology: Thrombolytic Therapy and Acute Stroke Treatments  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P7.001  

Author Institution:University of Iowa, Iowa City, IA  University of Iowa Hospitals and Clinics, Iowa City, IA  University of New Mexico, Albuquerque, NM  University of Miami Miller School of Medicine, Miami, FL  Yale University, New Haven, CT  The University of Kansas Health System, Kansas City, KS  Mount Sinai Hospital, New York, NY  University of South Florida College of Medicine , Tampa, FL  Cooper University Hospital, Camden, NJ  Boston Medical Center, Boston, MA  University of Texas At Houston, Houston, TX  Texas Stroke Institute, Dallas, TX  St Louis University , Philadelphia, PA  Pomona valley, Montclair, CA  ProMedica Stroke Network, Toledo, OH  Yale School of Medicine & Yale - New Haven Hospital, Flatwoods, KY  Harvard Medical School/ Beth Israel Deaconess Medical Center, Boston, MA  University of Iowa , Iowa City, IA  TTUHSC-SOM, Lubbock  Neurology Dept., Lubbock, TX  Vall de Hebron, barcelona, Spain  Kansas Medical Center, Kansas City, KS  University of Kansas, Kansas City, KS  Mt Sinai, Newyork City, NY  Cooper , Old Bridge, NJ  University of Texas, Houston, TX  St Louis University , Saint Louis, MO  University of South Florida, Tampa, FL  Valley Baptist Medical Center, Harlingen, TX